Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

2 Bekeken
administrator
administrator
07/10/23

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

  • categorie

Laat meer zien

0 Comments Sorteer op

Geen reacties gevonden

Facebook Reacties

Volgende